Aethlon Medical (NASDAQ:AEMD – Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) EPS for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.10. During the same period in the prior year, the business posted ($1.30) earnings per share.
Aethlon Medical Stock Performance
Shares of AEMD opened at $0.43 on Tuesday. The business has a 50-day moving average of $0.40 and a 200-day moving average of $0.51. Aethlon Medical has a 1 year low of $0.24 and a 1 year high of $2.35.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on Aethlon Medical
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
See Also
- Five stocks we like better than Aethlon Medical
- What is the S&P 500 and How It is Distinct from Other Indexes
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- What Are Dividend Champions? How to Invest in the Champions
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
